Hinge Health (HNGE) Insider Group Sells $121M of Stock

Insight Holdings Sells Hinge Health Stock

LLC Insight Holdings Group recently parted with a large block of Hinge Health, Inc. (NYSE: HNGE) shares. According to a regulatory filing with the SEC, the group disposed of 1,466,667 shares on June 29, 2026. The transaction was executed at an average price of $82.84 per share, bringing the total value of the sale to roughly $121.49 million. This move followed a busy month of June that included several other buy and sell transactions by the same group.

Where Hinge Health Stock Trades Today

With shares trading near $81.48 on Tuesday, Hinge Health finds itself positioned well within its 52-week trading bounds. The stock has touched a low of $30.08 and climbed as high as $107.00 over the past year. Its current price sits below its 50-day moving average of $92.61 while remaining above its 200-day moving average of $63.29. The company maintains an $8.47 billion market capitalization alongside a forward P/E ratio of 34.33.

Recent Insider Activity by Insight Holdings

The June 29 sale was part of a pre-arranged trading plan utilized by LLC Insight Holdings Group. Earlier in the month, the group made several other moves. On June 22, 2026, it sold 224,399 shares at an average price of $70.96 for a total of $15.92 million. A day later, on June 23, 2026, the group bought 112,477 shares and also sold 112,477 shares at $70.21. Additional acquisitions occurred on June 25 and June 29, when the group picked up 530,982 shares and 1,466,667 shares respectively through non-open market additions.

Analysts Set New Price Targets

Wall Street firms remain active on the stock. On October 16, 2026, Keybanc maintained its Overweight rating while lifting its price target to $140.00 from $125.00. Earlier, on October 12, 2026, Barclays kept an Overweight rating and pushed its target to $110.00. Needham followed suit on September 30, 2026, keeping a Buy rating with a $115.00 target. Baird kept a Neutral rating on September 22, 2026, adjusting its target to $90.00. Overall, the company draws a consensus buy recommendation from 16 analysts.

What Hinge Health Does

Hinge Health builds digital care systems designed to automate and scale musculoskeletal treatments using software and wearable technology. Its platform helps patients manage acute injuries, chronic joint pain, and post-surgical recovery through motion tracking and electrical nerve stimulation devices. The company primarily offers its services to self-insured employers across the United States.

Looking Ahead to Earnings and Filings

Investors are keeping an eye on Hinge Health as it heads toward its next scheduled financial results release on November 2, 2026. Because insider transactions provide a look at past portfolio adjustments, further SEC disclosures will show whether Insight Holdings continues to alter its stake in the health technology provider.